As Dr. Pinkerton explained, 70% of those on Lynkuet saw the frequency of their hot flashes cut in half after 12 weeks on the drug.
While hormone therapy is often the go-to treatment for menopause symptoms, it can “significantly” increase the risk of breast cancer recurrence in women with a history of the disease, the Breast Cancer Research Foundation says.
“It’s important that women know they have choices for treating moderate to severe hot flashes due to menopause, and today’s approval further expands a woman’s options for treating these symptoms,” Claire Gill, President and Founder of the National Menopause Foundation, said in a press release from Bayer, the manufacturer of the drug.
For Complete Cooking STEPS Please Head On Over To Next Page Or Open button (>) and don’t forget to SHARE with your Facebook friends.
